Advance Market Commitment

A market-shaping pattern in which sponsors or buyers commit in advance to purchase a qualifying product or outcome at stated terms, so that a credible demand signal pulls suppliers into a market before commercial buyers can finance it.

Also known as: AMC, advance purchase commitment, pull mechanism, demand guarantee, offtake commitment (in the narrower contractual sense).

Most impact-first capital works on the supply side. It funds an enterprise, absorbs a loss, lengthens a tenor, or guarantees a loan. An advance market commitment works on the demand side. It tells suppliers that if they build a product meeting a defined specification, a known buyer will be there at a known price. That promise can be the missing piece when the technology is feasible and the social case is strong, but no supplier will invest in capacity for a market that does not yet pay.

Context

The pattern applies when a needed product or outcome is technically possible but commercially stranded. The buyers who would eventually want it are too poor, too fragmented, too future-dated, or too uncertain to constitute a market a supplier can underwrite today. Think of a vaccine for a disease concentrated in low-income countries, a tonne of durable carbon removal, an off-grid energy product for rural households, a diagnostic for a neglected condition. In each case the supplier sees real cost and capacity risk against demand it cannot yet count on.

A foundation, family office, donor collaborative, development finance institution, or government agency closes that gap by committing in advance to buy. The commitment is conditional. It names a target product profile, a price, a quantity or a cap, and an eligibility test. If a supplier meets the profile, the sponsor buys at the agreed terms; if no supplier qualifies, no money moves. The structure converts a soft expectation of future need into a binding demand signal that a supplier’s board can treat as bankable.

For a family-office operator, the important distinction is that an AMC is not a grant and not ordinary procurement. A grant funds an organization; an AMC pays only for a delivered, qualifying product. Ordinary procurement buys what already exists; an AMC commits to buy something that doesn’t yet exist, precisely to bring it into being. The pattern belongs beside guarantees, catalytic first-loss capital, and blended finance because it shapes a market, but it is the one structure in that set that acts on demand rather than risk.

Problem

The supplier’s problem is a chicken-and-egg deadlock. Building capacity (a manufacturing line, a carbon-removal facility, a distribution network) requires capital, and capital requires demand the supplier can show a lender or an investment committee. But demand will not materialize until the product exists at scale and at a tolerable price, which requires the capacity that has not been built. Each side waits for the other. The result is a feasible product that no one finances.

Standard tools do not break this deadlock cleanly. A grant to a single supplier picks a winner before the field has competed and spends the money once. A subsidy on the supply side lowers cost but leaves the supplier still guessing whether buyers will appear. A research prize rewards invention but not the harder work of building affordable capacity. What the supplier needs is a credible buyer for a defined product at a defined price, durable enough to underwrite an investment decision against.

The trap on the sponsor’s side is the mirror image. A commitment that is too small, too vague, or too non-binding does not change any supplier’s behavior. A press-release pledge to “support the market,” a memorandum of intent with no price and no quantity, or a commitment a sponsor can quietly withdraw is reassuring in a meeting but it’s useless in a supplier’s capital plan. Worse, a sponsor can pre-purchase products that suppliers would have built anyway, then report the spending as market-shaping it never did.

Forces

• Credibility versus flexibility. The commitment has to be binding enough that a supplier’s board will underwrite capacity against it. The more binding it is, the less the sponsor can adjust as the field changes.
• Demand creation versus picking winners. A well-designed AMC defines a product profile and lets multiple suppliers compete to meet it. A poorly designed one is a sole-source contract wearing a market-shaping label.
• Price discipline versus participation. Set the price too low and no supplier enters; set it too high and the sponsor overpays for products that were coming anyway, eroding both additionality and budget.
• Funding certainty versus open-ended exposure. Suppliers need to know the money is real and ring-fenced. Sponsors need a cap so a successful program does not become an unbounded liability.
• Speed versus verification. A purchase should trigger only after an independent check that the product met the target profile, but verification adds time and cost the supplier feels.

Solution

Write the commitment as a facility with five named parts, the anatomy the field settled on through the vaccine and climate cases: guaranteed funding, a target product profile, an independent eligibility assessment, a price structure, and a demand forecast or cap.

Start with guaranteed, ring-fenced funding. The supplier must be able to treat the money as real and durable, not as a sponsor’s discretionary line that can be cut in a bad year. The commitment is typically backed by a legally binding agreement, an escrow or reserve, or a donor’s balance sheet with board authority and a multi-year horizon. State the term explicitly: a commitment that can lapse before a supplier finishes building capacity isn’t a demand signal.

Define the target product profile precisely. The profile is the specification a product must meet to qualify: efficacy and safety for a vaccine, durability and additionality for carbon removal, performance and affordability for an energy product. A vague profile invites disputes at the moment of purchase; a precise one lets multiple suppliers know exactly what they are building toward and lets an assessor say yes or no.

Build the eligibility test on independent assessment. A committee or verifier confirms that a candidate product meets the profile before any purchase triggers. This is the structural link to the Additionality Test and to independent verification: the assessment is what lets the sponsor claim later that the commitment, not luck, produced the qualifying product.

Set the price structure to change behavior without overpaying. The Gavi pneumococcal model used a higher starting price for the initial committed volume and a lower long-term tail price for subsequent supply, so the early commitment offset the cost of building capacity while the tail price approached a sustainable commercial level. The price must be high enough to make capacity investment rational and low enough that the sponsor is paying for additional behavior, not for products already on the way.

Cap the exposure with a demand forecast or a fixed commitment size. The forecast disciplines the budget and tells suppliers the rough scale of the opportunity. The cap protects the sponsor: once committed volume or committed dollars are exhausted, the obligation ends.

How It Plays Out

Consider a $900M single-family office with a $120M foundation and a family-council mandate around climate. The family wants to support durable carbon removal, a field where the technology works at small scale but where almost no buyers exist, so suppliers cannot raise the capital to build larger facilities. A grant to one supplier would pick a winner; an offset purchase on the spot market would buy cheap, low-durability credits and invite an impact-washing critique.

The foundation instead joins a pooled advance market commitment alongside several corporate and philanthropic buyers, structured as a donor collaborative. The pool commits to purchase qualifying durable carbon removal at a fixed price through a defined end date. The family’s share is a $6M binding commitment over five years.

If a supplier builds a facility and delivers verified, qualifying removal, the pool buys at the committed price and the family’s share is drawn down. If no supplier qualifies, the family’s $6M is never spent. The binding signal existed the whole time, and it is what justified suppliers’ capacity decisions. The family council can see the commitment beside the foundation’s grants and program-related investments, with the verification record attached.

The family’s annual report makes a bounded claim. It does not say the family “removed N tonnes of carbon.” It says the foundation’s $6M commitment, as part of a larger pool, helped underwrite the capacity decisions of suppliers who delivered verified removal against a defined profile, and it names the verification standard. That claim is testable against the eligibility assessments and the suppliers’ own statements about what the demand signal changed.

The original pull-mechanism evidence sits behind the climate case. In 2007, donors committed $1.5B to a pneumococcal advance market commitment to accelerate access to a vaccine for low-income countries. Gavi’s own evaluation is careful: the commitment helped bring supply forward and supported uptake, but not every outcome can be attributed to the AMC alone. That caveat is the discipline the pattern requires. A sponsor reports what the structure plausibly changed, not the entire downstream result.

A failure case is cheaper at signing and emptier later. A family office issues a “commitment to support” an early climate-removal supplier with no price, no quantity, no eligibility test, and a clause letting it withdraw at will. The supplier cites the commitment in its fundraising as an AMC. No capacity decision actually depends on it, because no supplier’s board could underwrite a promise that soft. When the family later reports the pledge as market-shaping, it is claiming credit for a signal that changed nothing.

Consequences

Benefits. An advance market commitment can move supplier behavior with capital that may never be spent, which gives it a different efficiency profile from a grant. When suppliers compete to meet the profile, the structure avoids picking a winner prematurely and lets the field find the lowest-cost qualifying supply. The commitment is also legible to a supplier’s investment committee in a way a grant to a peer is not: it is a demand the board can model. And because purchase triggers only on verified eligibility, the structure produces exactly the evidence an outside verifier needs to test the impact claim.

Liabilities. The design is unforgiving. A commitment that is too small relative to the capacity decision, too vague in its product profile, or too easy to withdraw will not change any supplier’s behavior, and the sponsor will have spent legal and design cost for no market effect. Pricing is genuinely hard: too low and no one enters, too high and the sponsor overpays for products that were coming anyway. The structure also requires real administrative capacity (an eligibility committee, verification, contract management) that a small family office may not have in-house. That gap is part of why pooled and donor-collaborative forms are common.

The second-order effect is governance. Once a family signs an advance market commitment, it has to treat a contingent demand promise as a portfolio position with its own reporting. The dashboard should show committed dollars, drawdowns against verified purchases, remaining exposure, the term, and the impact claim, beside funded grants and investments. As with a guarantee facility, a commitment the reporting stack cannot see is not under operational control. And the family has to decide, before signing, whether the commitment is meant to prove a market and step down as commercial demand arrives, or to sustain a market that will never be fully commercial. Both can be legitimate; pretending an open-ended subsidy is a temporary bridge is not.

Related Articles

Sources

• Center for Global Development, Advance Market Commitment, current access 2026 — the originating policy work on AMCs as a pull mechanism, including the design of the pneumococcal pilot and the distinction between conditional purchase and subsidy commitments.
• Gavi, the Vaccine Alliance, Pneumococcal Advance Market Commitment: How It Works and Pneumococcal AMC: Outcomes and Impact Evaluation, current access 2026 — the operational mechanics (donor funds, product eligibility, supply agreements, long-term price commitments, independent assessment) and the attribution caveat the pattern must carry.
• Ruth Levine et al., Advance Market Commitments, in Invest in Results, current access 2026 — the operational anatomy of an AMC: guaranteed funding, target product profile, independent eligibility assessment, starting and tail prices, and demand forecast.
• RMI, An Advance Market Commitment for Near-Zero-Emissions Concrete, 2025 — a recent application of the pull-mechanism design to a hard-to-abate industrial material, showing how the structure transfers from health to climate.

This entry describes a structural pattern and is not legal, tax, or investment advice. Consult qualified counsel and tax advisors licensed in your jurisdiction before adopting any structure described here.